US3753975A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Evomonoside derivative
Assignee: Roche Diagnostics GmbH
•
Filing: 1970-12-01
•
Granted: 1973-08-21
•
Expires: 1990-12-01
Abstract
Abstract EVOMONOSIDE ETHERS AND/OR ESTERS OF THE FORMULA 17-(2-(O=)-2,5-DIHYDROFUR-4-YL),3-((3-(R3-O-),4-(R2-O-), 5-(R1-O-),5-(R2-O-),6-CH3-TETRAHYDROPYRAN-2-YL)-O-),14- HO-ANDROSTANE WHEREIN ONE OR TWO OF THE SUBSTITUENTS R1, R2 AND R3 IS LOWER ALKYL OR ALKOXYALKYL OR WHEREIN THE SUBSTITUENTS R2 AND R3 TOGETHER REPRESENT A LOWER ALKYLIDENE RADICAL, AND THE REMAINING SUBSTITUENTS ARE HYDROGEN OR ACYL. THESE EVOMONOSIDE DERIVATIVES ARE HIGHLY EFFECTIVE THERAPEUTIC AGENTS AND ARE SUITABLE FOR ORAL ADMINISTRATION IN THE TREATMENT OF CARDIAC INSUFFICIENCY.
Inventors
- 👤 F Kaiser
- 👤 W Voigtlander
- 👤 W Schaumann
- 👤 K Stach
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 18:21
CPC Classifications
C; C07; C07J; C07J19/00
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1976-08-20 | 1977-02-19 | 1977-08-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1980-08-20 | 1981-02-19 | 1981-08-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1984-08-20 | 1985-02-19 | 1985-08-21 | $7700.00 | Window Closed / Lapsed |